Skip to main content
54°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Outlook Therapeutics Inc
(NQ:
OTLK
)
6.040
-0.010 (-0.17%)
Streaming Delayed Price
Updated: 3:52 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Outlook Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
November 09, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
November 08, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
November 08, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Analyst Ratings for Outlook Therapeutics
November 03, 2023
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
November 07, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
November 07, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
OUTLOOK THERAPEUTICS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. (NASDAQ: OTLK)
November 07, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm
November 06, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
November 06, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
OTLK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 06, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
OTLK SHAREHOLDER ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
November 06, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor Concerns
November 03, 2023
Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the
Via
Benzinga
Exposures
Product Safety
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
November 03, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook
November 02, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Thursday. The Dow traded up 1.51% to 33,775.43 while the NASDAQ rose 1.71% to 13,284.72....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today?
November 02, 2023
Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has
Via
Benzinga
Dow Jumps 400 Points; Starbucks Posts Upbeat Earnings
November 02, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 400 points on Thursday. The Dow traded up 1.21% to 33,675.91 while the NASDAQ rose 1.46% to 13,251.90. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges Over 1%; US Initial Jobless Claims Increase To 217,000
November 02, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.82% to 33,548.07 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 20, 2023
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 20, 2023
Via
Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 19, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 19, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 19, 2023
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 18, 2023
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
NASDAQ:OTLK Shareholder Notice: Investigation over Potential Wrongdoing at Outlook Therapeutics, Inc.
September 28, 2023
San Diego, CA -- (SBWIRE) -- 09/28/2023 -- An investigation on behalf of investors in shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) was announced over potential breaches of fiduciary duties by...
Via
SBWire
NASDAQ:OTLK Investor Notice: Investigation over Possible Securities Laws Violations by Outlook Therapeutics, Inc.
September 11, 2023
San Diego, CA -- (SBWIRE) -- 09/11/2023 -- Outlook Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 13, 2023
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.